Aggregation of neutrophils in patients with arterial hypertension dyslipidemic patients receiving rosuvastatin

Purpose: To establish the dynamics of tneutrophils ability to aggregation in patients with arterial hypertension (AH) and dyslipidemia receiving rosuvastatin. Examined 30 patients with AH of 1—2 grade and dyslipidemia type IIb, risk of 4, middle age. Control submitted on 26 healthy people of similar age. Patients received rosuvastatin 5 mg per night. In patients with AH and dyslipidemia increased neutrophil aggregation was revealed. As a result the use of rosuvastatin in patients with AH and dyslipidemia during 16 weeks led to normalization of lipids, lipid peroxidation and aggregation of neutrophils.

neutrophils, lipid peroxidation, arterial hypertension, dyslipidemia, rosuvastatin